Genomic Testing for Autism spectrum disorder, PANDAS & PANs

Genomics is a field of biology that studies the complete set of DNA in an organism, known as the genome. It investigates genome structure, function, evolution, and mapping. Genomics plays a critical role in understanding gene interactions, diagnosing genetic disorders, and advancing personalized medical treatments.

IntellxxDNA genomic testing looks at genetic variations related to nutrients, inflammation, mitochondria, toxicant removal, immune function, brain scaffolding, brain plasticity, and neurotransmitters and then brings research-based information to interpretation and treatment. 

Deciding whether the cost is justified is a personal decision influenced by various factors. Many families with children on the autism spectrum invest significant amounts in tests, therapies, and treatments, often with varying degrees of success. Families dealing with PANDAS or PANS often face challenges in accessing effective treatments for their children, who might experience persistent or recurring symptoms. Families of children with ADHD sometimes spend substantial amounts monthly on stimulant medications. By identifying potential genetic contributors through IntellxxDNA testing, we can leverage evidence-based insights to determine which dietary adjustments, vitamins, supplements, lifestyle modifications, and/or medications are most likely to benefit your child.

Precision medicine is a personalized approach to healthcare that customizes treatment based on an individual's unique characteristics, such as their genetic profile, lifestyle, and environmental factors. By utilizing genomic testing, precision medicine aims to uncover the specific causes of a disease in each person, allowing for the identification of the most effective treatments tailored to their unique needs.